These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26311117)

  • 21. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinoma.
    Jiang XM; Yu XN; Huang RZ; Zhu HR; Chen XP; Xiong J; Chen ZY; Huang XX; Shen XZ; Zhu JM
    J Cancer Res Clin Oncol; 2016 Nov; 142(11):2309-17. PubMed ID: 27601163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
    Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
    PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.
    Lu XY; Xi T; Lau WY; Dong H; Zhu Z; Shen F; Wu MC; Cong WM
    Ann Surg Oncol; 2011 Aug; 18(8):2210-7. PubMed ID: 21308485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells.
    Lin L; Liang H; Wang Y; Yin X; Hu Y; Huang J; Ren T; Xu H; Zheng L; Chen X
    BMC Cancer; 2014 Nov; 14():879. PubMed ID: 25425543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
    Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of β-catenin and HNF-1α and their influence on prognosis in human hepatocellular carcinoma].
    Shi J; Yin F
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):587-91. PubMed ID: 25430024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression of stemness factors Oct4 and Nanog predict liver resection.
    Yin X; Li YW; Zhang BH; Ren ZG; Qiu SJ; Yi Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2877-87. PubMed ID: 22461131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.
    Zhou ZJ; Dai Z; Zhou SL; Fu XT; Zhao YM; Shi YH; Zhou J; Fan J
    Int J Cancer; 2013 Mar; 132(5):1080-9. PubMed ID: 22821376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL; Dai Z; Zhou ZJ; Wang XY; Yang GH; Wang Z; Huang XW; Fan J; Zhou J
    Hepatology; 2012 Dec; 56(6):2242-54. PubMed ID: 22711685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
    Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
    Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
    Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from HBV-related hepatocellular carcinoma.
    Yang Z; Zhuang L; Yu Y; Zhou W; Lu Y; Xu Q; Tang B; Chen X
    Discov Med; 2015 Dec; 20(112):349-56. PubMed ID: 26760979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.